TISSIUM

TISSIUM is a biotechnology startup based in France, established in 2013 with a focus on addressing the challenge of tissue reconstruction and restoration of natural function. The company's pioneering work began with the discovery of their first polymer at the labs of Bob Langer and Jeff Karp at MIT, showcasing the potential to revolutionize tissue reconstruction in various therapeutic areas. TISSIUM's approach to product development involves leveraging proprietary polymers, activation technologies, and delivery devices. The startup has established an integrated platform for innovation, design, commercialization, and manufacturing to support internal programs and co-development partnerships with key players in the medtech industry. Notably, TISSIUM recently secured a significant €50.00M Series D investment on 23 May 2023, with participation from prominent investors including Sofinnova Partners, Crédit Mutuel Innovation, Mérieux Equity Partners, Cathay Health, and Fonds Stratégique d'Investissement.